In order to characterize the actions of xenoestrogens, it is essential to possess a solid portrait of the physiological effects of exogenous estradiol. We assessed effects of three doses of exogenous estradiol (E2) (0.1, 1.0 and 10 µg/kg/day) given between postnatal days 21 and 33 on the mammary gland morphology and gene expression profiles of male and female rats compared to vehicle-treated controls. The male mammary gland was more responsive to E2 treatment than in females, with 509 genes regulated >2-fold in a dose-dependent manner in males and only 174 in females. In males, E2 treatment significantly (P < 0.01) increased the number of terminal end buds (TEBs) and the expression of proliferating cell nuclear antigen (PCNA) protein (P < 0.05), both of which are indicators of proliferation. This change was linked to a significant increase (P < 0.05) in the expression of the gene encoding amphiregulin, which is known to induce TEB formation. There was also a dose-dependent increase (P < 0.001) in the estrogen-regulated gene encoding the progesterone receptor. In intact females, despite lack of changes in mammary morphology, we observed a dose-dependent increase (P < 0.05) in the expression of genes encoding three milk proteins: whey acidic protein, casein beta and casein kappa. There was a significant (P < 0.05) downregulation of both estrogen receptors in response to E2 treatment. These results suggest that mammary glands of male rats are very sensitive to exogenous E2 during development post-weaning. The dose-dependent increase observed in amphiregulin and progesterone receptor gene expression was linked to morphological changes and represents a reliable and sensitive tool to evaluate estrogenicity. In contrast, intact weanling female rats were less responsive.
DohertyLFBromerJGZhouYAldadTSTaylorHS. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: An epigenetic mechanism linking endocrine disruptors to breast cancer. Horm Cancer2010; 1: 146–55.
2.
SchragerSPotterBE. Diethylstilbestrol exposure. Am Fam Physician2004; 69: 2395–400.
3.
Titus-ErnstoffLHatchEEHooverRNPalmerJGreenbergERRickerWKaufmanRNollerKHerbstALColtonTHartgeP. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer2001; 84: 126–33.
4.
FentonSE. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology2006; 147: S18–24.
5.
RoyJRChakrabortySChakrabortyTR. Estrogen-like endocrine disrupting chemicals affecting puberty in humans – A review. Med Sci Monit2009; 15: RA137–45.
6.
de RondeWPolsHAvan LeeuwenJPde JongFH. The importance of oestrogens in males. Clin Endocrinol (Oxf)2003; 58: 529–42.
7.
ForneyJPMilewichLChenGTGarlockJLSchwarzBEEdmanCDMacDonaldPC. Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia. J Clin Endocrinol Metab1981; 53: 192–9.
8.
SchindlerAEEbertAFriedrichE. Conversion of androstenedione to estrone by human tissue. J Clin Endocrinol Metab1972; 35: 627–30.
9.
SiiteriPK. Adipose tissue as a source of hormones. Am J Clin Nutr1987; 45: 277–82.
10.
CouseJFKorachKS. Estrogen receptor null mice: What have we learned and where will they lead us?Endocr Rev1999; 20: 358–417.
11.
TaylorAHAl AzzawiF. Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol2000; 24: 145–55.
12.
HallJMMcDonnellDP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology1999; 140: 5566–78.
13.
SajiSJensenEVNilssonSRylanderTWarnerMGustafssonJA. Estrogen receptors alpha and beta in the rodent mammary gland. Proc Natl Acad Sci USA2000; 97: 337–42.
14.
KregeJHHodginJBCouseJFEnmarkEWarnerMMahlerJFSarMKorachKSGustafssonJASmithiesO. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA1998; 95: 15677–82.
15.
KorachKSCouseJFCurtisSWWashburnTFLindzeyJKimbroKSEddyEMMigliaccioSSnedekerSMLubahnDBSchombergDWSmithEP. Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res1996; 51: 159–86.
16.
RuanWKleinbergDL. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology1999; 140: 5075–81.
17.
ChengGWeihuaZWarnerMGustafssonJA. Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland. Proc Natl Acad Sci USA2004; 101: 3739–46.
18.
Hilakivi-ClarkeLChoEClarkeR. Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring. Oncol Rep1998; 5: 609–16.
19.
Mandrup KR, Hass U, Christiansen S and Boberg J. Perinatal ethinyl oestradiol alters mammary gland development in male and female Wistar rats. Int J Androl 2012;35:385–96.
20.
UmekitaYSoudaMHatanakaKHamadaTYoshiokaTKawaguchiHTanimotoA. Gene expression profile of terminal end buds in rat mammary glands exposed to diethylstilbestrol in neonatal period. Toxicol Lett2011; 205: 15–25.
21.
Hilakivi-ClarkeLChoEdeAssisSOlivoSEalleyEBoukerKBWelchJNKhanGClarkeRCabanesA. Maternal and prepubertal diet, mammary development and breast cancer risk. J Nutr2001; 131: 154S–7S,..
22.
LatendresseJRBucciTJOlsonGMellickPWeisCCThornBNewboldRRDelclosKB. Genistein and ethinyl estradiol dietary exposure in multigenerational and chronic studies induce similar proliferative lesions in mammary gland of male Sprague-Dawley rats. Reprod Toxicol2009; 28: 342–53.
23.
WangXJBartolucci-PageEFentonSEYouL. Altered mammary gland development in male rats exposed to genistein and methoxychlor. Toxicol Sci2006; 91: 93–103.
24.
YouLSarMBartolucciEJMcIntyreBSSriperumbudurR. Modulation of mammary gland development in prepubertal male rats exposed to genistein and methoxychlor. Toxicol Sci2002; 66: 216–25.
25.
ColditzGA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst1998; 90: 814–23.
26.
EliassenAHMissmerSATworogerSSSpiegelmanDBarbieriRLDowsettMHankinsonSE. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst2006; 98: 1406–15.
27.
KeyTApplebyPBarnesIReevesG. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst2002; 94: 606–16.
28.
EwertzMHolmbergLTretliSPedersenBVKristensenA. Risk factors for male breast cancer – A case-control study from Scandinavia. Acta Oncol2001; 40: 467–71.
29.
HsingAWMcLaughlinJKCoccoPCo ChienHTFraumeniJFJr. Risk factors for male breast cancer (United States). Cancer Cause Control1998; 9: 269–75.
30.
JohnsonKCPanSMaoY. Risk factors for male breast cancer in Canada, 1994–1998. Eur J Cancer Prev2002; 11: 253–63.
31.
CabanesAWangMOlivoSdeAssisSGustafssonJAKhanGHilakivi-ClarkeL. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis2004; 25: 741–8.
32.
NagasawaHYanaiRShodonoMNakamuraTTanabeY. Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17 beta level in rats. Cancer Res1974; 34: 2643–6.
33.
Hilakivi-ClarkeLOnojafeIRaygadaMChoESkaarTRussoIClarkeR. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer1999; 80: 1682–8.
34.
MurrillWBBrownNMZhangJXManzolilloPABarnesSLamartiniereCA. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis1996; 17: 1451–7.
35.
PengJHZhuJDMiMTLiFJCaiLDongJZZhangHXZhaoYXueRL. Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis. Eur J Cancer Prev2010; 19: 110–9.
36.
ChalabiNCoxamVSatihSDaviccoMJLebecquePFontanaLBignonYJBernard-GallonDJ. Gene signature of rat mammary glands: Influence of lifelong soy isoflavones consumption. Mol Med Rep2010; 3: 75–81.
37.
MoralRWangRRussoIHLamartiniereCAPereiraJRussoJ. Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol2008; 196: 101–12.
38.
MoralRWangRRussoIHMailoDALamartiniereCARussoJ. The plasticizer butyl benzyl phthalate induces genomic changes in rat mammary gland after neonatal/prepubertal exposure. BMC Genomics2007; 8: 453–453.
39.
SuYSimmenFAXiaoRSimmenRC. Expression profiling of rat mammary epithelial cells reveals candidate signaling pathways in dietary protection from mammary tumors. Physiol Genomics2007; 30: 8–16.
40.
ThomsenARAlmstrupKNielsenJESorensenIKPetersenOWLeffersHBreinholtVM. Estrogenic effect of soy isoflavones on mammary gland morphogenesis and gene expression profile. Toxicol Sci2006; 93: 357–68.
41.
YouLBartolucciEJ. Gene expression profiles in mammary gland of male rats treated with genistein and methoxychlor. Environ Toxicol Pharmacol2004; 18: 161–72.
42.
SchulzeADownwardJ. Navigating gene expression using microarrays – A technology review. Nat Cell Biol2001; 3: E190–5.
43.
SuzukiAUrushitaniHWatanabeHSatoTIguchiTKobayashiTOhtaY. Comparison of estrogen responsive genes in the mouse uterus, vagina and mammary gland. J Vet Med Sci2007; 69: 725–31.
44.
ReevesPGNielsenFHFaheyGCJr. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr1993; 123: 1939–51.
45.
SinghalRBadgerTMRonisMJ. Reduction in 7,12-dimethylbenz[a]anthracene-induced hepatic cytochrome-P450 1A1 expression following soy consumption in female rats is mediated by degradation of the aryl hydrocarbon receptor. J Nutr2007; 137: 19–24.
46.
SinghalRShankarKBadgerTMRonisMJ. Hepatic gene expression following consumption of soy protein isolate in female Sprague-Dawley rats differs from that produced by 17{beta}-estradiol treatment. J Endocrinol2009; 202: 141–52.
47.
Irizarry RA, Ooi SL, Wu Z and Boeke JD. Use of mixture models in a microarray-based screening procedure for detecting differentially represented yeast mutants. Stat Appl Genet Mol Biol 2: Article1, 2003.
48.
KrzywinskiMScheinJBirolIConnorsJGascoyneRHorsmanDJonesSJMarraMA. Circos: An information aesthetic for comparative genomics. Genome Res2009; 19: 1639–45.
49.
SinghalRShankarKBadgerTMRonisMJ. Estrogenic status modulates aryl hydrocarbon receptor–mediated hepatic gene expression and carcinogenicity. Carcinogenesis2008; 29: 227–36.
50.
VandesompeleJDe PreterKPattynFPoppeBVan RoyNDe PaepeASpelemanF. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol2002; 3. RESEARCH0034.
51.
DunnettCW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc1955; 50: 1096–121.
52.
WinerBJ. Statistical Principles in Experimental Design, New York, NY: McGraw-Hill, 1971, pp. 201–4.
53.
RussoJRussoIH. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat1996; 39: 7–20.
54.
CiarloniLMallepellSBriskenC. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci U S A2007; 104: 5455–60.
SacedaMLippmanMEChambonPLindseyRLPonglikitmongkolMPuenteMMartinMB. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol1988; 2: 1157–62.
57.
GroberOMMutarelliMGiuratoGRavoMCicatielloLDe FilippoMRFerraroLNassaGPapaMFParisOTaralloRLuoSSchrothGPBenesVWeiszA. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics2011; 12: 36–36.
58.
SchombergDW. Steroidal modulation of steroid secretion in vitro: an experimental approach to intra-follicular regulatory mechanisms. Adv Exp Med Biol1979; 112: 155–155.
59.
KwonSStedmanDBElswickBACattleyRCWelschF. Pubertal development and reproductive functions of Crl: CD BR Sprague-Dawley rats exposed to bisphenol A during prenatal and postnatal development. Toxicol Sci2000; 55: 399–406.
60.
LassurguèreJLiveraGHabertRJégouB. Time-and dose-related effects of estradiol and diethylstilbestrol on the morphology and function of the fetal rat testis in culture. Toxicol Sci2003; 73: 160–9.
61.
ChinoyNJRaoMV. Effect of estradiol benzoate on hormonal profile and steroidogenic organs of immature and adult male rats. Endokrinologie1982; 80: 287–287.
62.
DockeFRohdeWFreitagJDornerG. Sex-specific postnatal development of negative oestrogen feedback in rats. Exp Clin Endocrinol1988; 91: 301–10.
63.
LokeDFRatnamSSGohHH. Long-term oestrogen priming on basal and oestradiol-induced release of luteinising hormone secretion in male rats. Ann Acad Med Singapore1992; 21: 765–8.
64.
de AssisSKhanGHilakivi-ClarkeL. High birth weight increases mammary tumorigenesis in rats. Int J Cancer2006; 119: 1537–46.
65.
MoralRSantucci-PereiraJWangRRussoIHLamartiniereCARussoJ. In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: An experimental study in rats. Environ Health2011; 10: 5–5.
66.
HorwitzKBMcGuireWL. Estrogen control of progesterone receptor induction in human breast cancer: role of nuclear estrogen receptor. Adv Exp Med Biol1979; 117: 95–110.
67.
MohlaSClem-JacksonNHunterJB. Estrogen receptors and estrogen-induced gene expression in the rat mammary glands and uteri during pregnancy and lactation: changes in progesterone receptor and RNA polymerase activity. J Steroid Biochem1981; 14: 501–8.
68.
RussoJAoXGrillCRussoIH. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat1999; 53: 217–27.
69.
WangSCountermanLJHaslamSZ. Progesterone action in normal mouse mammary gland. Endocrinology1990; 127: 2183–9.
70.
ChenJRLazarenkoOPShankarKBlackburnMLLumpkinCKBadgerTMRonisMJ. Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. J Pharmacol Exp Ther2011; 336: 734–42.
71.
LiuYHHuangYShaoX. Effects of estrogen on genioglossal muscle contractile properties and fiber-type distribution in chronic intermittent hypoxia rats. Eur J Oral Sci2009; 117: 685–90.
72.
VeldersMSolzbacherMSchleipenBLaudenbachUFritzemeierKHDielP. Estradiol and genistein antagonize the ovariectomy effects on skeletal muscle myosin heavy chain expression via ER-beta mediated pathways. J Steroid Biochem Mol Biol2010; 120: 53–9.
73.
HatsumiTYamamuroY. Downregulation of estrogen receptor gene expression by exogenous 17beta-estradiol in the mammary glands of lactating mice. Exp Biol Med (Maywood)2006; 231: 311–6.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
